https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

A study from Valdecilla Hospital outlines how to optimize the use of monoclonal antibodies in migraine

28 de May de 2026

The Neurology Department of the Marqués de Valdecilla University Hospital (HUMV) has published a study offering new insights to improve preventive migraine treatment with monoclonal antibodies targeting CGRP (Calcitonin Gene-Related Peptide). The research was conducted by neurologists from the Headache Unit, led by Marcos Polanco, first author of the study, together with biotechnologist Gabriel Gárate, […]

Read more →

A conference organized by IDIVAL will address the opportunities offered by Horizon Europe to boost research and innovation in health

27 de May de 2026

Experts from the scientific, healthcare and management fields will analyze European funding, the role of population cohorts, and the transformation of the healthcare system through research. On June 2, a conference dedicated to the Horizon Europe programme will be held, aimed primarily at healthcare professionals and research managers, though also open to researchers, technical staff […]

Read more →

The SAM Project, led by IDIVAL, advances its fieldwork in Bayonne and Málaga

26 de May de 2026

The SAM Project (an acronym for Health, Social, Assets and Map), led by the Marqués de Valdecilla Research Institute (IDIVAL) with principal investigator Olga De Cos from the Health Economics group, continues to make progress in developing its social prescribing model with the completion of new fieldwork sessions in Bayonne and the simultaneous advancement of […]

Read more →

Spanish researchers analyze the use of treosulfan in allogeneic transplantation for myeloid neoplasms in real-world clinical practice

21 de May de 2026

The use of new conditioning regimens in allogeneic hematopoietic stem cell transplantation could improve treatment tolerance in patients with myeloid neoplasms. This is suggested by the study “Real-world experience of treosulfan in allogeneic stem cell transplantation in adult patients with myeloid malignancies”, which examines real-world clinical experience with this drug. The study focuses on the […]

Read more →

IDIVAL participates in the European Care@Home project to promote artificial intelligence in home-based care for older adults

19 de May de 2026

The initial meeting (Kick-off Meeting) of the European project “AI that Cares for Aging at Home” (Care@Home) has taken place in Kaunas (Lithuania). This international initiative aims to transform the care of older adults through the use of artificial intelligence (AI). The project includes the participation of the Valdecilla Health Research Institute (IDIVAL), together with […]

Read more →

IDIVAL organizes the National Congress “Health and Digital Rights” in Granada

18 de May de 2026

Granada will host the National Congress on Health and Digital Rights on May 26, an event promoted by the Valdecilla Research Institute (IDIVAL) to analyze the main challenges posed by digital transformation in the healthcare sector and its impact on citizens’ rights. The congress, directed by Joaquín Cayón, head of IDIVAL’s Research Group on Health […]

Read more →

Santander to bring together National Specialists at the 5th Northern Headache Meeting “CEFANORTE 2026”

13 de May de 2026

Santander will host the 5th Northern Headache Meeting (CEFANORTE 2026), a leading scientific event dedicated to updating knowledge and promoting a multidisciplinary approach to headaches and migraine. The congress is organized by neurologists Julio Pascual and Vicente González‑Quintanilla from the Marqués de Valdecilla University Hospital and the Marqués de Valdecilla Research Institute (IDIVAL) on June […]

Read more →

A Valdecilla-led study shows that lung transplantation offers good survival in patients with advanced silicosis

12 de May de 2026

A nationwide multicentre study led by the Marqués de Valdecilla University Hospital demonstrates that lung transplantation is a safe and effective option in patients with advanced pneumoconiosis — mainly silicosis — an irreversible lung disease caused by prolonged inhalation of silica dust. The work has been published in the international scientific journal Respirology and is […]

Read more →

Valdecilla hosted a specialized course on multiple myeloma and new immunological therapies

6 de May de 2026

The Marqués de Valdecilla University Hospital held a theoretical‑practical course focused on the management of multiple myeloma and innovative anti‑BCMA immunotherapy strategies, bringing together Hematology specialists to address the latest advances in diagnosis, treatment, and clinical practice. Organized by the hospital’s Hematology and Hemotherapy Department, the training program aimed primarily to update knowledge on one […]

Read more →

Specialists in hematology meet in Santander to advance the management of immunotherapy in acute lymphoblastic leukemia

5 de May de 2026

The Valdecilla Virtual Hospital, in collaboration with the Hematology Department of the Marqués de Valdecilla University Hospital, is organizing the course “Management of Immunotherapy in Acute Lymphoblastic Leukemia (ALL)” on May 13 and 14. This advanced training program is aimed at pediatric onco‑hematologists and hematologists interested in this disease. The activity has the institutional support […]

Read more →